Trastuzumab Deruxtecan (+Pertuzumab) is now @US_FDA ✅in 1L Her2+ mBC off #DestinyBreast09! We 🗣️ this trial, findings, maintenance phase, & AEs w/ @stolaney1
Full 🗣️:
⭐️On OncBrothers & OncUpdates Website
⭐️Also on “Oncology Brothers” podcast
@OncUpdates#bcsm#OncTwitter
In 2025, many important and long-awaited studies were published. I included them but kept the algorithms unchanged, as there are open questions about how these data will impact practice, particularly in early and metastatic HER2+ disease and mTNBC.
@DFCI_BreastOnc#SABCS25
📚 #SABCS2024 SABCS2024 - Late-Breaking Presentations 1-01: Em mulheres ≥70 anos, a cirurgia imediata reduz recidiva local e mortalidade por câncer de mama, com benefícios mais evidentes a longo prazo. @UniofOxford#RobertHills
📚 Breast Cancer Research: Mulheres socialmente vulneráveis têm maior risco de câncer de mama avançado e mortalidade. O SVI destaca o impacto de fatores sociais e ambientais. Soluções como navegação de pacientes e mamografias móveis são essenciais. https://t.co/TJMVrpMy77
#SABCS23@OncoAlert@DrRBarroso
TNBC - Should neoadj pembrolizumab be given with dose-dense or q3w AC?
Our RWD showed similar outcomes in terms of safety. ddAC was associated with numerically higher pCR (66% vs 57%), especially in the stage III subgroup (55% vs 33%).
The question is what have I learned from this chronicle that could be helpful to all of you, and more specifically, how does my experience contribute to our collective understanding of partnerships between patients and clinicians in oncology? I have some thoughts.... 1/4 #ASCO23
With #ASCO23-week officially here, it is time for a #top10 list of breast abstracts! Several potentially practice-changing trials to be presented during the congress. Take a look, share if you found it useful and feel free to recommend additional impactful abstracts to add! #bcsm
Reading good review articles can shape ideas, help connecting the dots and understanding what’s coming ahead in science.
Here’s 10 review articles that helped me shape my views on breast oncology and drug development:
@Delta I received the two suitcases only today, but nothing from the stroller. no one gives me information. The online service does not work and I cannot speak on the phone. I changed cities already and I'm halfway through the trip and the inconvenience continues.
@Delta I need my bags and my baby's stroller! Delta is ruining my long-awaited vacation. I arrived in SFO on Friday and until now my 2 bags and the stroller have not been delivered to me! Absurd and total lack of respect and commitment to the customer.
@VoeGOLoficial a GOL, como quase sempre, atrasou o voo, perdi a conexão em SP, três horas de fila para ela me mandar num táxi para um hotel errado! Triste!!!
#SABCS22 is 4 weeks away! Excited for #bcsm updates including overall survival data, novel compound activity, tx sequencing info, molecular data to inform tx decision, & info about pregnancy post cancer.
Attached are the top 10 (yes, I cheated) I'm excited to see!
@oncoalert
Tomorrow we will have the honor to have Dr Aleix Prat lecturing about HER2DX: a new tool for personalizing management of pts with early HER2+ breast cancer. #dasaoncologia
BCLC 2022 Update Recommends ALBI score as a prognostic score. Do you hepatologists, surgeons and GI oncologists use the ALBI score in your clinical practice? https://t.co/coI6o9vz5Y… Please, help me with this knowlegde for thoughts about my master degree. TKs.